Aerovate Therapeutics Inc (AVTE) Stock
AVTE is no longer traded. Aerovate Therapeutics was delisted from the Nasdaq in April 2025.
Prices on this page are historical; the last trade was April 25, 2025 at $2.68.
Aerovate Therapeutics stock price history
AVTE final trading statistics
- Final close
- $2.68
- Final trading day
- Apr 25, 2025
- Market cap at delisting
- $77.68M
- Shares outstanding
- 28.98M
- Final 52-week range
- $1.25 – $25.29
- Avg. volume (final 3 mo.)
- 7,417
- All-time high (split-adj.)
- $1048.71 · Apr 2024
- All-time low (split-adj.)
- $48.09 · Jun 2024
- Return since IPO
- -88.3%
- Beta
- 0.95
- Book value / share
- $90.62
- Price / book
- 0.03
Aerovate Therapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$69.6M | -$27.94 |
| FY2023 | $0.00 | -$75.5M | -$2.88 |
| FY2022 | $0.00 | -$51.5M | -$2.11 |
| FY2021 | $0.00 | -$23.0M | -$37.18 |
| FY2020 | $0.00 | -$9.0M | -$3.70 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Aerovate Therapeutics Inc
Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Aerovate Therapeutics stock FAQ
What happened to Aerovate Therapeutics stock?
Aerovate Therapeutics stock was delisted from the Nasdaq. Its final close was $2.68 on April 25, 2025.
Is AVTE stock still trading?
No. AVTE was delisted from the Nasdaq in April 2025 and no longer trades on a U.S. exchange.
What was the last price of AVTE stock?
AVTE closed at $2.68 on its final trading day, April 25, 2025, for a market value of about $77.68M.
What were Aerovate Therapeutics's revenue and earnings in its last full fiscal year?
Aerovate Therapeutics reported revenue of $0.00 and net income of -$69.6M in fiscal 2024, its last full year as a public company.
When did Aerovate Therapeutics go public?
Aerovate Therapeutics Inc stock began trading on June 30, 2021.